0.90Open1.05Pre Close33 Volume97 Open Interest78.00Strike Price2.24KTurnover57.97%IV0.52%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type-0.4642Delta0.3171Gamma173.56Leverage Ratio-0.9093Theta-0.0003Rho-80.56Eff Leverage0.0086Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet